David R. Epstein - 27 May 2022 Form 4 Insider Report for Evelo Biosciences, Inc.

Role
Director
Signature
/s/ Daniel S. Char, Attorney-in-Fact for David R. Epstein
Issuer symbol
EVLO on OTC
Transactions as of
27 May 2022
Net transactions value
+$25,000
Form type
4
Filing time
31 May 2022, 16:07:15 UTC
Previous filing
03 Jun 2022
Next filing
01 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVLO Common Stock Purchase $25,000 +17,123 +26% $1.46* 84,080 27 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.